Morgan Stanley analyst Erin Wright reiterates PetMed Express (NASDAQ:PETS) with a Underweight and maintains $17 price target.
Morgan Stanley Reiterates Underweight on PetMed Express, Maintains $17 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.